• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Alterations in coagulation and fibrinolysis during sepsis.

作者信息

Kidokoro A, Iba T, Fukunaga M, Yagi Y

机构信息

Department of Surgery, Juntendo Urayasu Hospital, Juntendo University School of Medicine, Chiba, Japan.

出版信息

Shock. 1996 Mar;5(3):223-8. doi: 10.1097/00024382-199603000-00010.

DOI:10.1097/00024382-199603000-00010
PMID:8696988
Abstract

Circulating levels of thrombin-antithrombin III complex (TAT) and plasmin-alpha 2 plasmin inhibitor complex (PIC) in 49 septic patients (23 patients with organ dysfunction (OD), 26 without OD) and 11 postgastrectomy patients were measured to determine the significance of the coagulation-fibrinolytic systems in the development of OD. Tissue plasminogen activator (t-PA), plasminogen activator inhibitor 1 (PAI-1), and thrombomodulin were also measured. The mean level of TAT on the day when OD occurred was significantly higher compared with the maximum level of TAT in septic patients without OD (P < .01) or postoperative patients (P < .01). There was no difference in PIC levels between the three groups. The TAT/PIC ratio was significantly higher in septic patients with OD compared with the other groups (P < .001). Septic patients with OD showed higher levels of PAI-1 (P < .001) but not of t-PA. Thrombomodulin levels were significantly higher in the septic patients with OD compared with the others (P < .001). We conclude that suppression of the fibrinolytic system contributes to the imbalance between coagulation and fibrinolysis, and that this hypercoagulable millieu on the endothelial surface leads to the onset of OD.

摘要

相似文献

1
Alterations in coagulation and fibrinolysis during sepsis.
Shock. 1996 Mar;5(3):223-8. doi: 10.1097/00024382-199603000-00010.
2
Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.弥散性血管内凝血和血栓性血小板减少性紫癜患者血浆中组织型纤溶酶原激活物抑制因子-I(PAI-I)及tPA/PAI-1复合物的水平。
Clin Appl Thromb Hemost. 2001 Jul;7(3):229-33. doi: 10.1177/107602960100700309.
3
Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.糖尿病中血液凝固和纤维蛋白溶解的激活:通过血浆凝血酶 - 抗凝血酶III复合物和纤溶酶 - α2 - 纤溶酶抑制剂复合物水平进行评估
Thromb Res. 1989 Sep 15;55(6):727-35. doi: 10.1016/0049-3848(89)90303-4.
4
Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.使用分子标志物研究弥散性血管内凝血中凝血与纤溶之间的平衡
Blood Coagul Fibrinolysis. 1994 Oct;5(5):829-32. doi: 10.1097/00001721-199410000-00022.
5
Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.关于正常妊娠、分娩及产褥期子宫胎盘循环中激肽释放酶-激肽系统的凝血-纤溶系统研究。
Agents Actions Suppl. 1992;38 ( Pt 2):320-9.
6
Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.急性心肌梗死患者血浆及血小板中的纤溶酶原激活物抑制剂-1
Jpn Circ J. 2000 Aug;64(8):547-53. doi: 10.1253/jcj.64.547.
7
Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.早期抑制激活的纤溶系统可预测发热内科患者的微生物感染、休克及死亡率。
Thromb Haemost. 2001 Aug;86(2):543-9.
8
An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.尽管凝血被大量激活,但增强的纤维蛋白溶解可预防弥散性血管内凝血中多器官功能衰竭的发生。
Crit Care Med. 2001 Jun;29(6):1164-8. doi: 10.1097/00003246-200106000-00015.
9
Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer.原发性未经治疗的癌症患者中凝血和纤溶激活的低发生率
Thromb Haemost. 1990 Nov 30;64(3):361-4.
10
Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy.
Thromb Res. 1990 Sep 15;59(6):955-65. doi: 10.1016/0049-3848(90)90119-w.

引用本文的文献

1
Clinical value of TAT, PIC and t-PAIC as predictive markers for severe sepsis in pediatric patients.TAT、PIC和t-PAIC作为儿童严重脓毒症预测标志物的临床价值。
Front Pediatr. 2024 Mar 18;12:1336583. doi: 10.3389/fped.2024.1336583. eCollection 2024.
2
Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction.二氯乙酸酯可逆转脓毒症引起的肝代谢功能障碍。
Elife. 2021 Feb 22;10:e64611. doi: 10.7554/eLife.64611.
3
Proposal of the Definition for COVID-19-Associated Coagulopathy.新型冠状病毒肺炎相关凝血病的定义提案。
J Clin Med. 2021 Jan 7;10(2):191. doi: 10.3390/jcm10020191.
4
Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation.SOFA 评分变化对预测脓毒症相关性弥散性血管内凝血患者 28 天死亡率的作用。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029618824044. doi: 10.1177/1076029618824044.
5
Assessment of clinical outcome of children with sepsis outside the intensive care unit.评估重症监护室外脓毒症患儿的临床转归。
Eur J Pediatr. 2018 Dec;177(12):1775-1783. doi: 10.1007/s00431-018-3247-2. Epub 2018 Sep 17.
6
Plasminogen Activator Inhibitor 1 for Predicting Sepsis Severity and Mortality Outcomes: A Systematic Review and Meta-Analysis.纤溶酶原激活物抑制剂 1 预测脓毒症严重程度和死亡结局的价值:系统评价和荟萃分析。
Front Immunol. 2018 Jun 18;9:1218. doi: 10.3389/fimmu.2018.01218. eCollection 2018.
7
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC.关于修改日本血栓与止血学会(JSTH)脓毒症相关性弥散性血管内凝血(DIC)诊断标准的提议
Clin Appl Thromb Hemost. 2018 Apr;24(3):439-445. doi: 10.1177/1076029617720069. Epub 2017 Jul 27.
8
Anticoagulant modulation of inflammation in severe sepsis.严重脓毒症中抗凝对炎症的调节作用
World J Crit Care Med. 2015 May 4;4(2):105-15. doi: 10.5492/wjccm.v4.i2.105.
9
The efficacy and safety of different anticoagulants on patients with severe sepsis and derangement of coagulation: a protocol for network meta-analysis of randomised controlled trials.不同抗凝剂对严重脓毒症及凝血紊乱患者的疗效和安全性:一项随机对照试验网络荟萃分析方案
BMJ Open. 2014 Dec 22;4(12):e006770. doi: 10.1136/bmjopen-2014-006770.
10
Biomarkers of endothelial cell activation in early sepsis.早期脓毒症中内皮细胞活化的生物标志物。
Shock. 2013 May;39(5):427-32. doi: 10.1097/SHK.0b013e3182903f0d.